Arrowhead Pharmaceuticals (0HI3.L) Stock Price

$13.14 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    1

  • Technical

    6

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Arrowhead Pharmaceuticals, AI stock picks, stock alerts and much more.

Sign up

0HI3.L AI Stock Analysis

AI stock analysis for 0HI3.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Arrowhead Pharmaceuticals (0HI3.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Arrowhead Pharmaceuticals (0HI3.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Arrowhead Pharmaceuticals (0HI3.L), currently trading at $13.14, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About 0HI3.L

LSE

  • Arrowhead Pharmaceuticals, Inc.

  • Symbol

    0HI3.L

  • Market

    LSE

  • Industry

    Biotechnology

  • Market Cap

    1.8B

Similar Stocks

0I0X.L Codexis
0I0X.L		 $2.27
3.6%
4
ONT.L Oxford Nanopore Technologies plc
ONT.L		 £123.1
0.8%
6
SAR.L Sareum Holdings
SAR.L		 £15.65
6.8%
2
0K1R.L Viridian Therapeutics
0K1R.L		 $13.33
8.3%
5
AVCT.L Avacta Group Plc
AVCT.L		 £31.25
0.8%
3

News

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives $41.44 Consensus Target Price from Analysts

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives $41.44 Consensus Target Price from Analysts
April 23, 2025. ETF Daily News
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Sold by Russell Investments Group Ltd.

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Sold by Russell Investments Group Ltd.
April 17, 2025. ETF Daily News
This type of cholesterol is a risk factor for heart disease. Emerging drugs from Lilly and Amgen could treat it.

This type of cholesterol is a risk factor for heart disease. Emerging drugs from Lilly and Amgen could treat it.
April 7, 2025. Livemint
10,080 Shares in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Acquired by Envestnet Portfolio Solutions Inc.

10,080 Shares in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Acquired by Envestnet Portfolio Solutions Inc.
March 29, 2025. ETF Daily News

0HI3.L Alternative Data

Web Traffic

Arrowhead Pharmaceuticals receives an estimated 33613 monthly visitors to arrowheadpharma.com.

  • Web Traffic

    33613

  • Change from Previous Month

    29.7%

  • 3 Month Change

    85.1%

  • YoY Change

    85.1%

News Mentions

Arrowhead Pharmaceuticals was mentioned 1 times in the news yesterday.

  • News Mentions

    1

  • Daily Change

    50%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Twitter Followers

Arrowhead Pharmaceuticals has 3,649 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.

  • Twitter Followers

    3649

  • Daily Change

    0%

  • 1 Month Change

    0.1%

  • 3 Month Change

    0.6%

Facebook Engagement

Arrowhead Pharmaceuticals has engaged 0 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

  • 3 Month Change

    0%

LinkedIn Followers

58,776 are following Arrowhead Pharmaceuticals on LinkedIn, up by 5.2% over the last month.

  • LinkedIn Followers

    58776

  • Daily Change

    0.1%

  • 1 Month Change

    5.2%

  • 3 Month Change

    22.6%

Job Postings

Arrowhead Pharmaceuticals currenly has an estimated 47 open job postings, up by 4.4% over the last month.

  • Job Postings

    47

  • Daily Change

    0%

  • 1 Month Change

    4.4%

  • 3 Month Change

    113.6%

Reddit Mentions

Arrowhead Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

LinkedIn Employees

According to LinkedIn, Arrowhead Pharmaceuticals has 555 employees.

  • LinkedIn Employees

    555

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.9%

Business Outlook

According to employee reviews, the business outlook among employees at Arrowhead Pharmaceuticals is 67 out of 100 (bullish).

  • Business Outlook

    67

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

0HI3.L Financials

0HI3.L Key Metrics

  • Total Revenue

    $2.5M

  • Net Income

    -$173.1M

  • Earnings per Share

    -$1.39

  • Free cash flow

    -$153.8M

  • EBITDA

    -$148.2M

  • EBITDA Ratio

    -59.2936

  • Total Assets

    $1B

0HI3.L 2-year Revenue & Income
0HI3.L 2-year Free Cash Flow

0HI3.L Technicals

0HI3.L SMA
0HI3.L RSI

FAQ

What's the current price of Arrowhead Pharmaceuticals (0HI3.L) Stock?
The price of an Arrowhead Pharmaceuticals (0HI3.L) share is $13.14.

What's the market cap of Arrowhead Pharmaceuticals?
The current market cap of Arrowhead Pharmaceuticals is 1.8B.

Should I buy or sell 0HI3.L?
Arrowhead Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Arrowhead Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.

Is Arrowhead Pharmaceuticals a good investment?
The current analysis of Arrowhead Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Arrowhead Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Arrowhead Pharmaceuticals (0HI3.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Arrowhead Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Arrowhead Pharmaceuticals (0HI3.L) that investors often compare it to?
Arrowhead Pharmaceuticals (0HI3.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.

What is the forecast for Arrowhead Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Arrowhead Pharmaceuticals' stock price to be around $13.26 in 2026. Starting from the current price of $13.14, this represents a 0.9% change in price, indicating a neutral outlook for the stock.

How to buy Arrowhead Pharmaceuticals (0HI3.L) Stock?
Arrowhead Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Arrowhead Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.